Reuters Highlights Washington Albertsons Opioid Trial Following National Settlement July 14, 2026 Reuters recently highlighted the start of Washington State’s trial against Albertsons, one of the remaining opioid cases proceeding after the company’s previously announced $774 million nationwide settlement. The state alleges Albertsons’ pharmacy practices contributed to the opioid epidemic by failing to adequately identify and address warning signs associated with opioid prescriptions. Albertsons denies the allegations. […] Read More
A Pensacola doctor indicted in Northwest Florida’s Fifth Pill Mill Case in Two Years June 26, 2026 A federal grand jury has indicted Pensacola physician Edward Scott Morrison on 41 counts related to the alleged unlawful distribution of controlled substances, marking another significant criminal case involving prescription drug practices in Northwest Florida. According to the U.S. Department of Justice, the indictment was announced as part of the 2026 National Health Care Fraud Takedown, a […] Read More
LP Attorney Cameron Stephenson Appointed to Plaintiffs’ Executive Committee in GLP-1 Vision Loss MDL February 24, 2026 On February 23, 2026, the United States District Court for the Eastern District of Pennsylvania appointed Cameron Stephenson, a shareholder at Levin Papantonio, to the Plaintiffs’ Executive Committee in the consolidated federal litigation involving glucagon-like peptide-1 (GLP-1) receptor agonist drugs and alleged non-arteritic anterior ischemic optic neuropathy (NAION). In a case management order, Judge Karen […] Read More